ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
Dow Jones
39.512,84
0,32%
Euro vs US Dollar
1,07875
0,00%
Bitcoin
61.127,47
0,54%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Anika Therapeutics Inc (ANIK)

  7. Anika Therapeutics Inc (ANIK) News

ANIK

Anika Therapeutics (ANIK)

Anika Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ANIK
DatumZeitQuelleÜberschriftSymbolFirma
08/05/202423h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANIKAnika Therapeutics Inc
08/05/202422h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
08/05/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
08/05/202422h08GlobeNewswire Inc.Anika Announces CFO TransitionNASDAQ:ANIKAnika Therapeutics Inc
08/05/202422h05GlobeNewswire Inc.Anika Reports First Quarter 2024 Financial ResultsNASDAQ:ANIKAnika Therapeutics Inc
03/05/202422h01GlobeNewswire Inc.Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ANIKAnika Therapeutics Inc
18/04/202422h01GlobeNewswire Inc.Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024NASDAQ:ANIKAnika Therapeutics Inc
02/04/202414h00GlobeNewswire Inc.Anika to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:ANIKAnika Therapeutics Inc
13/03/202421h05GlobeNewswire Inc.Anika Reports Fourth Quarter and Year-End 2023 Financial ResultsNASDAQ:ANIKAnika Therapeutics Inc
13/03/202412h03IH Market NewsMixed Futures Amidst Quiet Economic Schedule; Oil Prices ClimbNASDAQ:ANIKAnika Therapeutics Inc
08/03/202422h01GlobeNewswire Inc.Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ANIKAnika Therapeutics Inc
07/03/202401h30Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
27/02/202422h01GlobeNewswire Inc.Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024NASDAQ:ANIKAnika Therapeutics Inc
26/02/202415h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
13/02/202415h00GlobeNewswire Inc.Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual MeetingNASDAQ:ANIKAnika Therapeutics Inc
09/02/202417h09Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
24/01/202420h27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
22/01/202415h29Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ANIKAnika Therapeutics Inc
19/01/202422h52Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANIKAnika Therapeutics Inc
12/01/202422h35Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
28/11/202315h00GlobeNewswire Inc.Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market ReleaseNASDAQ:ANIKAnika Therapeutics Inc
07/11/202322h05GlobeNewswire Inc.Anika to Participate in Upcoming Investor ConferencesNASDAQ:ANIKAnika Therapeutics Inc
02/11/202321h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
02/11/202321h05GlobeNewswire Inc.Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the BusinessNASDAQ:ANIKAnika Therapeutics Inc
10/10/202315h00GlobeNewswire Inc.Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023NASDAQ:ANIKAnika Therapeutics Inc
03/10/202322h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIKAnika Therapeutics Inc
21/09/202313h55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
19/09/202315h00GlobeNewswire Inc.Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual MeetingNASDAQ:ANIKAnika Therapeutics Inc
15/09/202322h01GlobeNewswire Inc.Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ANIKAnika Therapeutics Inc
12/09/202315h00GlobeNewswire Inc.Anika to Participate in the Sidoti Small Cap Virtual Investor ConferenceNASDAQ:ANIKAnika Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ANIK

Kürzlich von Ihnen besucht

NYSE
DOW
Dow
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten